Talk:Schott Pharma

Latest comment: 10 days ago by Elisabeth at SCHOTT in topic Update: Production and Manufacturing

Some additional references

edit

Hi fellow Wikipedians,

Whilst I was looking for additional sources for this article, I came across the following that are yet to be cited within the text. Please feel to use these if you feel they are helpful:

https://www.sueddeutsche.de/wirtschaft/schott-corona-impfung-pharma-boerse-1.5722401

https://www.wallstreet-online.de/nachricht/18094756-schott-pharma-forecasts-fy-25-slowdown-due-to-reduced-syringe-growth

https://www.finance-magazin.de/finanzierungen/boersengaenge/schott-pharma-konkretisiert-boersengang-162978/

https://transkript.de/artikel/2022/schott-gliedert-pharma-glaeser-aus-und-plant-ipo/

https://www.deraktionaer.de/artikel/aktien/nach-biontech-neues-ipo-aus-mainz-schott-pharma-zeichnung-ab-morgen--20339588.html

https://www.handelsblatt.com/unternehmen/mittelstand/familienunternehmer/schott-pharma-boersengang-noch-im-jahr-2023-moeglich/28928326.html

https://cleanroomtechnology.com/schott-eyes-new-plant-in-china-188687

https://www.pharmaceutical-technology.com/contractors/commercial-packaging/schott-packaging/

Tynewyrd (talk) 13:06, 24 June 2024 (UTC)Reply

Governance / “needs expansion” templates

edit

Hi, I was wondering if anyone could provide the reasoning behind the "needs expansion" templates. While I get why one might want to add historical financial results, I don't see the value of detailed lists of board members (especially true for parent company board and supervisory board members). This increases the risk of incorrect or outdated information.

To support my point, the first version is already wrong:

Parent Company Board of Directors
  • Frank Heinricht (CEO of Schott AG) [1]
  • Almuth Steinkühler (Chief Financial Officer of Schott AG)[2]

References

  1. Cite error: The named reference :4 was invoked but never defined (see the help page).
  2. Kolf, Ingo (2024-05-15). "Kurs bricht ein: Schott Pharma: Trübe Aussichten führen zu drastischem Kurseinbruch". FinanzNachrichten.de (in German). Retrieved 2024-06-24.

Almuth Steinkühler isn't part of the parent company’s board of directors, and she also isn't SCHOTT AG's CFO, but rather Schott Pharma's CFO. Hence, I moved the section here.

If there’s no guideline to keep it, I also suggest deleting the section “Independent Supervisory Board” and reconsidering the detailed list of production sites (which also both incomplete and regularly changing). Thanks for your input! Elisabeth at SCHOTT (talk) 10:47, 6 November 2024 (UTC)Reply

Update: Production and Manufacturing

edit

Hi all, I would like to suggest an update to the section. First, Schott Pharma now has locations across 15 countries instead of 14. Second, I propose replacing the current list structure (which is both incomplete and inaccurate) with a summary of Schott Pharma's production locations. Then the incomplete template could also be removed.

Proposed text:

The company is headquartered in Mainz and operates in 17 locations across 15 countries. Its main manufacturing activities are located in Europe, the Americas, and Asia.
In Europe, the company’s production sites are located in Germany, Switzerland, Hungary, Serbia, Russia, Italy, and France.
Schott Pharma operates production facilities in the United States and in Mexico, and in South America in Brazil, Argentina, and Colombia.
In Asia, it operates productions in China, Indonesia, and India (through a joint venture with the Serum Institute of India and TPG).

Sources:

Let me know if this would work. Thanks! Elisabeth at SCHOTT (talk) 13:47, 2 March 2026 (UTC)Reply

Edit request reply 22-MAY-2026

edit

  Edit request declined  

Regards,  Spintendo  13:02, 22 May 2026 (UTC)Reply

@Spintendo, thanks for reviewing the edit request. I may not have explained my intention clearly enough. My aim was to replace the existing list-style “Production & Manufacturing” section with a concise prose summary, not to add to the list.
I would also be happy with a shorter version, for example:
== Production and Manufacturing ==
Schott Pharma is headquartered in Mainz, Germany, and operates manufacturing sites across Europe, North America, South America and Asia.[1]
Its business is divided into two divisions: …
Would this address the WP:NOTDIRECTORY concern? Thanks in advance. Elisabeth at SCHOTT (talk) 08:15, 15 June 2026 (UTC)Reply
  1. "About us". schott-pharma.com. SCHOTT Pharma AG & Co. KGaA. Retrieved 2 March 2026.